Summary
Working muscle plays a central role in the control of lipid metabolism. Increased physical activity induces a number of positive changes in the metabolism of lipoproteins: serum triglycerides are lowered by the increased lipolytic activity and the production of native high density lipoprotein (HDL) particles is increased. The increased lecithin: cholesterol acyltransferase activity leads to an increased production of HDL2, which in addition is catabolised more slowly due to a decreased activity of hepatic lipase. The 3 effects explain the increased HDL levels of endurance trained individuals. These effects have been demonstrated in cross-sectional as well as longitudinal studies by different groups, and can be induced by training, independent of changes in body weight. The influence of endurance activity on the quality and quantity of low density lipoprotein (LDL) particles is a further reason for the antiatherogenic potential of increased physical activity. It has been shown by several groups that small dense LDL particles represent a particular risk factor for atherosclerosis. Recent studies presented strong evidence that LDL level and composition can be influenced favourably by physical activity. In addition to the direct influence of physical activity on lipids and lipoproteins, physical exercise may improve the disturbances of haemorheological factors, particularly those associated with hypertriglyceridaemia.
In conclusion, there is increased evidence that physical activity is able to favourably influence all 3 components of the atherogenic lipoprotein phenotype: the HDL concentration increases, the concentration of small dense LDL decreases, and serum triglycerides are reduced.
Similar content being viewed by others
References
Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-con-taining lipoprotein families. Progress in Lipid Research 30: 105–138, 1991
Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thrombosis and Haemostasis 60: 491–494, 1988
Allison FG, Iammarino RM, Metz KF, Skrinar GS, Kuller LH, et al. Failure of exercise to increase high density lipoprotein cholesterol. Journal of Cardiac Rehabilitation 1: 257–265, 1981
Aimér LO, Janzon L. Low vascular fibrinolytic activity in obesity. Thrombosis Research 6: 171–175, 1975
Aimér LO, Nilsson IM. On fibrinolysis in diabetes mellitus. Acta Medica Scandinavica 198: 101–106, 1975
American College of Sports Medicine. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Medicine and Science in Sports and Exercise 22: 265–274, 1990
Andersen P, Arnesen H, Hjermann I. Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men. Acta Medica Scandinavica 209: 199–202, 1981
Assmann G, Betteridge DJ, Gotto Jr AM, Steiner G. Management of hypertriglyceridemic patients. A. Treatment classifications and goals. American Journal of Cardiology 68: 30A–34A, 1991
Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). American Journal of Cardiology 70: 733–737, 1992
Astrand PO. Why exercise. Medicine and Science in Sports and Exercise 24: 153–162, 1992
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. Journal of the American Medical Association 260: 1917–1921, 1988
Austin MA, King MC, Vranizan K, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82: 495–506, 1990
Baker TT, Allan D, Lei KY, Willcox KK. Alterations in lipid and protein profiles of plasma lipoproteins in middle-aged men consequent to an aerobic exercise program. Metabolism 35: 1037–1043, 1986
Ballantyne FC, Clark RS, Simpson HS, Ballantyne D. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 31: 433–437, 1982
Barkia A, Puchois P, Ghalim N. Differential role of apolipoprotein AI containing particles in cholesterol efflux from adipose cells. Arteriosclerosis 87: 135–146, 1991
Baumstark MW, Berg A, Halle M, Rensing UFE, Roskamm H, et al. Low-density lipoprotein subfractions and severity of angiographically assessed coronary artery disease. Abstract. Program and Abstracts, 2nd International Symposium on Multiple Risk Factors in Cardiovascular Disease, Osaka, pp. 83, 1992
Baumstark MW, Frey I, Berg A, Keul J. Acute and delayed effects of exhaustive exercise on serum lipoproteins. II. Composition and distribution of low density lipoprotein subfractions. Eurpean Journal of Applied Physiology 66: 526–530, 1992
Baumstark MW, Halle M, Frey I, Berg A, Keul J. Composition and distribution of LDL-subfractions in sedentary and endurance trained men with hypercholesterolemia. Abstract. 9th International Symposium on Atherosclerosis, pp. 193, International Atherosclerosis Society, 1991
Baumstark MW, Kreutz W, Berg A, Frey I, Keul J. Structure of human low-density lipoprotein subfractions, determined by X-ray small-angle scattering. Biochemica et Biophysica Acta 1037: 48–57, 1990
Berg A, Frey I, Keul J. Apoprotein profile in healthy males and its relationship to maximum aerobic capacity (MAC). Clinica Chimica Acta 161: 165–171, 1986a
Berg A, Halle M, Baumstark MW, Frey I, Keul J. Physical activity, lipids and lipoprotein metabolism. The benefit of exercise and training in hyperlipidemia. In Watson et al. (Eds) Exercise and disease, pp. 26–36, CRC Press, Boca Raton, 1992
Berg A, Jakob E, Keul J. Physiological energetic in sports. In Wieser et al. (Eds) Energy transformations in cells and organisms, pp. 241–247, Thieme-Verlag, Stuttgart, 1989
Berg A, Jakob E, Lehmann M, Dickhuth HH, Huber G, et al. Aktuelle Aspekte der modernen Ergometrie. Pneumologie 44: 2–13, 1990
Berg A, Johns J, Baumstark M, Kreutz W, Keul J. HDL subfractions after a single, extended episode of physical exercise. Atherosclerosis 47: 231–240, 1983
Berg A, Keul J. Influence of maximum aerobic capacity and relative body weight on the lipoprotein profile in athletes. Atherosclerosis 55: 225–231, 1985
Berg A, Lehmann M, Keul J. Körperliche Aktivität bei Gesunden und Koronarkranken, 2nd ed., Thieme Verlag, Stuttgart, 1986b
Berg A, Ringwald G, Keul J, Deus B. Serum lipoprotein cholesterol in male athletes in different sports. Journal of Clinical Chemistry and Clinical Biochemistry 18: 707, 1980
Blair SN, Kohl III HW, Paffenbarger RS, Clark DG, Cooper KH, et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. Journal of the American Medical Association 262: 2395–2401, 1989
Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 81: 470–476, 1990
Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, et al. Regression of coronary artery disease as a result of intensive lipid-lower-ing therapy in men with high levels of apoprotein B. New England Journal of Medicine 323: 1287–1297, 1990
Brownell KD, Bachorik PS. Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise. Circulation 65: 477–484, 1982
Calvalho de Souza J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, et al. Association between coagulation factors VII and X with triglyceride rich lipoproteins. Journal of Clinical Pathology 41: 940–944, 1988
Chance B, Leigh JS, Clark BJ, Maris J, Kent J, et al. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: A steady-state analysis of the work/energy cost transfer function. Proceedings of the National Academy of Sciences of the United States of America 82: 8384–8388, 1985
Chandrashekhar Y, Anand IS. Exercise as a coronary protective factor. American Heart Journal 122: 1723–1739, 1991
Collet X, Perret B, Simard G, Raffai E, Marcel YL. Differential effects of lecithin and cholesterol on the immunoreactivity and conformation of apolipoprotein A-I in high density lipoproteins. Journal of Biological Chemistry 266: 9145–9152, 1991
Cook TC, Laporte RE, Washburn RA, Traven ND, Slemenda CW, et al. Chronic low level physical activity as a determinant of high density lipoprotein cholesterol and subfractions. Medicine and Science in Sports and Exercise 18: 653–657, 1986
Cortner JA, Le NA, Coates PM, Bennett MJ, Cryer DR. Determinants of fasting plasma triglyceride levels — metabolism of hepatic and intestinal lipoproteins. European Journal of Clinical Investigation 22: 158–165, 1992
Cullinane E, Siconolfi S, Saritelli A, Thomson P. Acute decrease in serum triglycerides with exercise: is there a threshold for an exercise effect. Metabolism 31: 844–847, 1982
Cuppers HJ, Erdmann D, Berger M. Glucose tolerance, serum insulin and serum lipids in athletes. In Kindermann et al. (Eds) Sportmedizin für Breiten- und Leistungssport, pp. 163–168, Demeter Verlag, Gräfelfmg, 1980
Dattilo AM, Krisetherton PM. Effects of weight reduction on blood lipids and lipoproteins — a meta-analysis. American Journal of Clinical Nutrition 56: 320–328, 1992
Davis PG, Bartoli WP, Durstine JL. Effects of acute exercise intensity on plasma lipids and apolipoproteins in trained runners. Journal of Applied Physiology 72: 914–919, 1992
Dufaux B, Assmann G, Hollmann W. Plasma lipoproteins and physical activity: a review. International Journal of Sports Medicine 3: 123–136, 1982
Dufaux B, Assmann G, Order U, Hoederath A, Hollmann W. Plasma lipoproteins, hormones and energy substrated during the first days after prolonged exercise. International Journal of Sports Medicine 2: 256–260, 1981
Dufaux B, Order U, Müller R, Hollmann W. Delayed effects of prolonged exercise on serum lipoproteins. Metabolism 35: 105–109, 1986
Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, et al. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proceedings of the National Academy of Sciences of the United States of America 84: 3224–3228, 1987
Epstein SE, Rosing DR, Brakman P, Redwood DR, Astrup T. Impaired fibrinolytic response to exercise in patients with type IV hyperlipoproteinaemia. Lancet 2: 631–634, 1970
Estelles A, Tormo G, Aznar J, Espana F, Tormo V. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Thrombosis Research 40: 373–383, 1985
Farell PA, Maksud MG, Pollock MG, Foster G, Anholm J, et al. A comparison of plasma cholesterol, triglycerides and high density cholesterol in speed skaters, weight lifters and non-athletes. European Journal of Applied Physiology and Occupational Physiology 48: 77–82, 1982
Fielding CJ, Fielding PE. Purification and substrate specificity of lecithin cholesterol acyltransferase from human plasma. FEBS Letters 15: 355–358, 1971
Foster DM, Chait A, Albers JJ, Failor RA, Harris C, et al. Evidence for kinetic heterogeneity among human low density lipoproteins. Metabolism 35: 685–696, 1986
Franklin BA, Gordon S, Timmis GC. Amount of exercise necessary for the patient with coronary artery disease. American Journal of Cardiology 69: 1426–1432, 1992
Frey I, Baumstark MW, Berg A. Acute and delayed effects of prolonged exercise on serum lipoproteins. I. Concentration and composition of high density lipoprotein subfractions. European Journal of Applied Physiology 66: 521–525, 1993
Frey I, Baumstark MW, Berg A, Keul J. Influence of acute maximal exercise on lecithin: cholesterol acyltransferase activity in healthy adults of differing aerobic performance. European Journal of Applied Physiology and Occupational Physiology 62: 31–35, 1991
Frey I, Kamps H, Baumstark MW, Berg A, Keul J. Distribution of lipoprotein species (LpA-I,LpA-I:A-II) in serum and HDL subfractions of untrained and trained normolipemic men. Clinica Chimica Acta 211: 167–173, 1992
Fruchart JC. High-density lipoprotein particles, nutrition and arteriosclerosis. Bibliotheca Nutritio et Dieta 49: 66–78, 1992
Fruchart JC, Ailhaud G. Recent progress in the study of apoA-I containing lipoprotein particles. Progress in Lipid Research 30: 145–150, 1992
Goldberg L, Elliot DL. The effect of exercise on lipid metabolism in men and women. Sports Medicine 4: 307–321, 1987
Goldberg IJ, Le NA, Paterniti JR. Lipoprotein metabolism during acute inhibition of hepatic triglycéride lipase in the cynomolgus monkey. Journal of Clinical Investigation 70: 1184–1192, 1982
Gordon DJ, Probstfield JL, Garrison RJ. High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79: 8–15, 1989
Gordon DJ, Rifkind BM. High-density lipoprotein — the clinical implications of recent studies. New England Journal of Medicine 321: 1311–1316, 1989
Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease and death. The Framingham study. Archives of Internal Medicine 141: 1128–1131, 1981
Gram J, Jespersen J. A selective depression of tissue plasminogen activator (t-PA) activity in euglobulins characterises a risk group among survivors of acute myocardial infarction. Thrombosis and Haemostasis 57: 137–139, 1987
Griffin BA, Skinner ER, Maughan RJ. The acute effect of prolonged walking and dietary changes on plasma lipoprotein concentrations and high-density lipoprotein subfractions. Metabolism 37: 535–541, 1988
Gris JC, Schved JF, Feugeas O, Aquilar-Martinez P, Arnaud A, et al. Impact of smoking, physical training and weight reduction on FVII, PAI-1 and hemostatic markers in sedentary men. Thrombosis and Haemostasis 64: 516–520, 1990
Gunnarsson R, Nyman D, Walinder O. Fibrinolytic activity and diabetes control: evidence for a relationship. Acta Medica Scandinavica 639: 23–24, 1980
Hamsten A, Walldius G, Szamosi A, Blombaeck M, DeFaire V, et al. Plasminogen activator inhibitor in plasma: risk for recurrent myocardial infarction. Lancet 2: 3–9, 1987
Hamsten A, Wiman B, DeFaire V, Blombaeck M. Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New England Journal of Medicine 313: 1557–1563, 1985
Hartung GH, Foreyt JP, Mitchell RE, Vlasek I, Gotto AM. Relationship of diet to high-density lipoprotein cholesterol in middle-aged marathon runners, joggers and inactive men. New England Journal of Medicine 302: 357–361, 1980
Hartung GH, Squires WG, Gotto AM. Effect of exercise training on plasma high-density lipoprotein cholesterol in coronary-disease patients. American Heart Journal 101: 181–184, 1981
Haskell W. The influence of exercise training on plasma lipids and lipoproteins in healthy and disease. Acta Medica Scandinavica 711 (Suppl.): 25–37, 1985
Haskell WL. Exercise-induced change in plasma lipids and lipoproteins. Preventive Medicine 13: 23–36, 1984
Haskell WL. Physical activity and health: need to define the required stimulus. American Journal of Cardiology 55: 4D–5D, 1985
Heinrich J, Schulte H, Balleisen L, Assmann G, van de Loo J. Predictive value of haemostatic variables in the PROCAM-study. Thrombosis and Haemostasis 65: 815, 1991
Herbert PN, Bernier DM, Cullinane EM, Edelstein L, Kantor MA, et al. High density lipoprotein metabolism in runners and sedentary men. Journal of the American Medical Association 252: 1034–1037, 1984
Herrick JB. Clinical features of sudden obstruction of the coronary arteries. Journal of the American Medical Association 59: 2015–2020, 1912
Holloszy JO, Skinner JS, Toro G, Cureton TK. Effect of a six-month program for endurance exercise on serum lipids of middle-aged men. American Journal of Cardiology 14: 753–760, 1964
Holmes Jr DR, Elveback RR, Fry RL, Kottke BA, Ellefson RD. Association of risk factor variables and coronary artery disease documented with angiography. Circulation 63: 293–299, 1981
Hurley BF, Hagberg JM, Allen WK, Seals DR, Young JC, et al. Effect of training on blood lactate levels during submaximal exercise. Journal of Applied Physiology 565: 1260–1264, 1984
Hurley BF, Nemeth PM, Martin WH, Hagberg JM, Dalsky GP, et al. Muscle triglyceride utilisation during exercise: effect of training. Journal of Applied Physiology 60: 562–567, 1986
Huttunen JK, Länsimies E, Voutilainen E, Ehnholm C, Hietanen E, et al. Effect of moderate exercise on serum lipoproteins — controlled clinical trial with special reference to serum high-density lipoproteins. Circulation 60: 1220–1229, 1979
Jansson E, Kaijser L. Substrate utilization and enzymes in skeletal muscle of extremely endurance-trained men. Journal of Applied Physiology 62: 999–1005, 1987
Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, et al. Plasma plasminogen activator inhibitor-1 in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis 9: 362–367, 1989
Kahn SE, Larson VG, Beard JC, Cain KC, Fellingham GW, et al. Effect of exercise on insulin action, glucose tolerance and insulin secretion in aging. American Journal of Physiology 358: E937–E943, 1990
Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. Journal of the American Medical Association 258: 1183–1186, 1987
Kantor MA, Cullinane EM, Herbert PN, Thompson P. Acute increase in lipoprotein lipase following prolonged exercise. Metabolism 33: 454–457, 1984
Kantor MA, Cullinane EM, Sady SP, Herbert PN, Thompson PD. Exercise acutely increases high density lipoprotein-cholesterol and lipoprotein lipase activity in trained and untrained men. Metabolism 36: 188–192, 1987
Karadi I, Kostner GM, Gries A, Nimpf J, Romics L, et al. Lipoprotein (a) and plasminogen are immunochemically related. Biochemica et Biophysica Acta 960: 91–97, 1988
Keul J. Muscle metabolism during long lasting exercise. In Howald et al. (Eds) Metabolic adaptation to prolonged physical exercise, pp. 31–42, Birkhäuser Verlag, Basel, 1975
Keul J, Doll E, Keppler D. Energy metabolism of human muscle, Karger Verlag, Basel, 1972
Kiens B, Jörgensen I, Lewis S, Jensen G, Lithell H, et al. Increased plasma HDL-cholesterol and apo AI in sedentary middle-aged men after physical conditioning. European Journal of Clinical Investigation 10: 203–209, 1980
Kiens B, Lithell H. Lipoprotein metabolism influenced by training-induced changes in human skeletal muscle. Journal of Clinical Investigation 83: 558–564, 1989
Koivisto V, Hendler R, Nadel E, Felig P. Influence of physical training on the fuel-hormone response to prolonged low intensity exercise. Metabolism 31: 192–197, 1982
Krauss RM. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. American Heart Journal 113: 578–582, 1987
Krauss RM. Low-density lipoprotein subclasses and risk of coronary artery disease. Current Opinion in Lipidology 2: 248–252, 1991
Krauss RM, Wood PD, Giotas C, Waterman D, Lindgren FT. Heparin-released plasma lipase activities and lipoprotein levels in distance runners. Abstract. Circulation 6 (Suppl.): II–73, 1979
Kullmer T, Kindermann W. Apolipoproteine und Lipoproteine bei unterschiedlicher körperlicher Aktivität und Leistungsfähigkeit. Klinische Wochenschrift 63: 1102–1109, 1985
Kuusi T, Kostiainen E, Vartiainen E, Pitkänen L, Ehnholm C, et al. Acute effects of marathon running on levels of serum lipoproteins and androgenic hormones in healthy males. Metabolism 33: 527–531, 1984
Kuusi T, Nikkilä EA, Saarinen P, Varjo P, Laitinen LA. Plasma high density lipoprotein HDL2, HDL3 and postheparin plasma lipase in relation to parameters of physical fitness. Arteriosclerosis 41: 209–219, 1982
Laffel GL, Braumwald E. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction. New England Journal of Medicine 311: 710–776, 1984
Lakka TA, Salonen JT. Physical activity and serum lipids — a cross-sectional population study in eastern Finnish men. American Journal of Epidemiology 136: 806–818, 1992
Lamon-Fava S, Fischer EC, Nelson ME, Evans WJ, Millar JS, et al. Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size, and apolipoproteins. Journal of Clinical Endocrinology and Metabolism 68: 17–21, 1989
Lamon-Fava S, McNamara JR, Farber HW, Hill NS, Schaefer EJ. Acute changes in lipid, lipoprotein, apolipoprotein, and low-density lipoprotein particle size after an endurance triathlon. Metabolism 38: 921–925, 1989
Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39: 1044–1048, 1990
Lehtonen A, Viikari J. The effect of vigorous physical activity at work on serum lipids with a special reference to serum high-density lipoprotein cholesterol. Acta Physiologica Scandinavica 104: 117–121, 1978a
Lehtonen A, Viikari J. Serum triglycerides and cholesterol and serum high-density lipoprotein cholesterol in highly physically active men. Acta Medica Scandinavica 294: 111–114, 1978b
Lehtonen A, Viikari J. Serum lipids in soccer and ice hockey players. Metabolism 29: 36–39, 1980
Lehtonen A, Viikari J, Engholm C. The effect of exercise on high density (HDL) lipoprotein apoproteins. Acta Medica Scandinavica 106: 487–488, 1979
Leon AS, Connett J, Jacobs DRJ, Rauramaa R. Leisure-time physical activity levels and risk of coronary heart disease and death. Journal of the American Medical Association 258: 2388–2395, 1987
Levy RI, Brensike JF, Epstein SE, Kelsey SF, Passamani ER, et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention Study. Circulation 69: 325–337, 1984
Lewis B, Watts GF, Lewis ES, Brunt JNH, Jackson P. Determinants of atherosclerosis progression in the STARS angiographic trial. Abstract. Program and Abstracts, 2nd International Symposium on Multiple Risk Factors in Cardiovascular Disease, pp. 50, Osaka, 1992
Loscalzo J. Lipoprotein(a). A unique risk factor for atherothrombotic disease. Arteriosclerosis 10: 672–679, 1990
Lowe GDO, Drummond MM, Lorimer AR, Hutton I, Forbes CD, et al. Relation between extent of coronary artery disease and blood viscosity. British Medical Journal 8: 673–674, 1980
Lowe GDO, Stromberg P, Forbes CD, McArdle BM, Lorimer AR, et al. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet 27: 472–475, 1982
Luc G, Bard JM, Lussier-Cacan S. High-density lipoprotein particles in octogenarians. Metabolism 40: 1238–1243, 1991
Lussier Cacan S, Bard JM, Boulet L. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III. Arteriosclerosis 78: 167–182, 1989
Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, et al. Apoprotein A-I as a marker of angiographically assessed coronary-artery disease. New England Journal of Medicine 309: 386–389, 1983
Marniemi J, Dahlström S, Kvist M, Seppänen A, Hietanen E. Dependence of serum lipids and lecithin: cholesterol acyltransferase levels on physical training in young men. European Journal of Applied Physiology and Occupational Physiology 49: 25–35, 1982
Marti B, Knobloch M, Riesen WF, Howald H. Fifteen-year changes in exercise, aerobic power, abdominal fat, and serum lipids in runners and controls. Medicine and Science in Sports and Exercise 23: 115–122, 1991
Marti B, Pekkanen J. Leben Läufer länger? Schweizerische Rundschau für Medizin 41: 1097–1100, 1988
McGinnis JM. The public health burden of a sedentary lifestyle. Medicine and Science in Sports and Exercise 24: S196–S200, 1992
Meade TW, Brozovic M, Chakrabarti R, Haines AP, Imeson JD, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 6: 533–537, 1986
Meade TW, North WRS, Chakrabarti R. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1: 1050–1054, 1980
Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease. Journal of the American College of Cardiology 9: 263–268, 1987
Moore R, Penfold W, Simpson R, Mann J, Turner R. High-density lipoprotein, lipid, and carbohydrate metabolism during increasing fitness. Annals of Clinical Biochemistry 16: 76–80, 1979
Moxley RT, Brakman P, Astrup T. Resting levels of fibrinolysis in blood in inactive and exercising men. Journal of Applied Physiology 28: 549–552, 1970
Nikkilä E, Taskinen M, Rehunen S, Härkönen M. Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism 27: 1661–1671, 1978
Nikkilä EA, Kuusi T, Taskinen MR and Tikkanen MJ. Regulation of lipoprotein metabolism by endothelial lipolytic enzymes. In Carlsson et al. (Eds) Treatment of hyperlipoproteinemia, Raven Press, New York, 1984
Nilsson-Ehle P, Garfinkel AS, Schotz MC. Lipolytic enzymes and plasma lipoprotein metabolism. Annual Review of Biochemistry 49: 667–693, 1980
Nordoy A, Illingworth DR, Conner WE, Goodnight S. Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia. Haemostasis 20: 65–72, 1990
Norum KR. Dietary fat and lipids. Nutrition Reviews 50: 30–37, 1992
Nye E, Carlson P, Kirstein P, Rossner S. Changes in high-density lipoprotein subfractions and other lipoproteins induced by exercise. Clinica Chimica Acta 113: 51–57, 1981
O’Conner GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 80: 234–244, 1989
Olofsson BO, Dahlen G, Nilsson TK. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. European Heart Journal 10: 77–82, 1989
Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, et al. Can life style changes reverse coronary heart disease? Lancet 336: 129–133, 1990
Oscai L, Palmer W. Muscle lipolysis during exercise: an update. Sports Medicine 6: 23–28, 1988
Paffenbarger RS, Hyde RT, Wing A, Hsieh CC. Physical activity, all-cause mortality and longevity of college alumni. New England Journal of Medicine 314: 605–613, 1986
Paffenbarger R, Hyde RT, Wing AL, Steinmetz CH. A natural history of athleticism and cardiovascular health. Journal of the American Medical Association 252: 491–495, 1984
Paul P. Effects of long lasting physical exercise and training on lipid metabolism. In Howald et al. (Eds) Metabolic adaptation to prolonged physical exercise, pp. 156–193, Birkhäuser Verlag, Basel, 1975
Pavano JA, Collucci M, Van der Wer F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. British Medical Journal 291: 575–576, 1985
Pekkanen J, Marti B, Nissinen A, Tuomilehto J, Punsar S, et al. Reduction of premature mortality by high physical activity: 20-year follow-up of middle-aged Finnish men. Lancet I: 1473–1477, 1987
Peltonen P, Marniemi J, Vuori I, Hietanen E. The effect of controlled physical training on lipid metabolism in man. A longitudinal study. Acta Physiologica Scandinavica 108: A26, 1980
Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, et al. Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 68: 35–40, 1987
Rader DJ, Castro G, Zech LA, Fruchart JC, Brewer HB. Invivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I, A-II. Journal of Lipid Research 32: 1849–1859, 1991
Ren J, Henriksson J, Katz A, Sahlin K. NADH content in type I and type II human muscle fibres after dynamic exercise. Biochemical Journal 251: 183–187, 1988
Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC. Apolipoproteins, membrane cholesterol domains and the regulation of cholesterol efflux. Journal of Lipid Research 33: 1091–1097, 1992
Rothblat GH, Phillips MC. Mechanism of cholesterol efflux from cells. Effects of acceptor structure and concentration. Journal of Biological Chemistry 257: 4775–4782, 1982
Sady SP, Thompson PD, Cullinane EM, Kantor MA, Domagala E, et al. Prolonged exercise augments plasma triglyceride clearance. Journal of the American Medical Association 256: 2552–2555, 1986
Savard J, Despres JP, Marcotte M, Theriault G, Tremblay A, et al. Acute effects of exercise on human adipose tissue metabolism. Metabolism 36: 458–480, 1987
Saxena U, Klein MG, Goldberg IJ. Transport of lipoprotein lipase across endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 88: 2254–2258, 1991
Scanu A, Lawn R, Berg K. Lipoprotein(a) and atherosclerosis. Annals of Internal Medicine 115: 209–218, 1991
Schnabel A, Kinderman W. Veränderungen von Lipiden und Lipoproteinen im Serum nach Körperarbeit unterschiedlicher Dauer. Deutsche Zeitschrift für Sportmedizin 33: 283–289, 1982
Schneider SH, Kim HC, Khachadurian AK, Ruderman NB. Impaired fibrinolytic response to exercise in type II diabetes: effects of exercise and physical training. Metabolism 37: 924–929, 1988
Schriewer H, Assmann G, Sandkamp M, Schulte H. The relationship of lipoprotein (a) [Lp(a)] to risk factors of coronary heart disease. Journal of Clinical Chemistry and Clinical Biochemistry 22: 591–596, 1984
Segrest JP, Jones MK, DeLoof H, Brouilette CG, Venkatachalapathi YV, et al. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. Journal of Lipid Research 33: 141–166, 1992
Shaw DA, McNaughton D. Relationship between blood fibrinolytic activity and body fatness. Lancet 1: 352–354, 1963
Simpson HCR, Meade TW, Stirling Y, Mann JI, Chakrabartt R, et al. Hypertriglyceridaemia and hypercoagulability. Lancet 9: 786–790, 1983
Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. New England Journal of Medicine 311: 874–877, 1984
Slattery ML, Jacobs DR. Physical fitness and cardiovascular disease mortality. American Journal of Epidemiology 127: 571–580, 1988
Slotte JP, Oram JF, Bierman EL. Binding of high density lipoproteins to cell receptor promotes translocation of cholesterol from intracellular membranes to the cell surface. Journal of Biological Chemistry 262: 904–912, 1987
Speiser W, Langer W, Pschaick A, Selmayr E, Ibe B, et al. Increased blood fibrinolytic activity after physical exercise: Comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program. Thrombosis Research 51: 543–555, 1988
Stein VT, Baumstark MW, Berg A, Keul J. Lipoprotein(a) — Serum-konzentrationen bei Personen mit unterschiedlicher Trainingsanamnese. In Bernett et al. (Eds) Sport und Medizin — Pro und Contra, pp. 530–532, W. Zuckschwerdt Verlag, Munich, 1991
Stremmel W, Diede H. Fatty acid uptake by human hepatoma cell lines represents a carrier-mediated uptake process. Biochemica et Biophysica Acta 1013: 218–222, 1989
Stubbe I, Hansson PG, Nilsson-Ehle. Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high density lipoprotein subfractions and composition. Metabolism 32: 1120–1128, 1983
Superko HR. Exercise training, serum lipids, and apoprotein particles: is there a change threshold. Medicine and Science and Sports in Exercise 23: 67–685, 1991
Taskinen MR, Nikkilä EA, Rehunen S, Gordin A. Effect of acute vigorous exercise on lipoprotein lipase activity of adipose tissue and skeletal muscle in physically active men. Artery 6: 471–483, 1980
Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, et al. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proceedings of the National Academy of Sciences of the United States of America 80: 6662–6666, 1983
Thompson PD, Cullinane EM, Sady SP, Flynn MM, Bernier DN, et al. Modest changes in high density lipoprotein concentration and metabolism with prolonged exercise training. Circulation 78: 25–34, 1988
Thompson PD, Cullinane EM, Sady SP, Flynn MM, Chenevert CB, et al. High density lipoprotein metabolism in endurance athletes and sedentary men. Circulation 84: 140–152, 1991
Thompson PD, Lazarus B, Cullinane LO, Henderson T, Musliner R et al. Exercise, diet or physical characteristics as determinants of HDL-levels in endurance athletes. Atherosclerosis 46: 333–339, 1983
Tran V, Weltman A. Differential effects of exercise on lipid and lipoprotein levels seen with changes in body weight: a meta analysis. Journal of the American Medical Association 254: 919–924, 1985
Tran V, Weltman A, Glass GV, Mood DP. The effects of exercise on blood lipids and lipoproteins: a meta-analysis of studies. Medicine and Science in Sports and Exercise 15: 393–402, 1983
Tsai MY, Yuan J, Hunninghake DB. Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies. Atherosclerosis 95: 35–42, 1992
Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35: 250–253, 1986
Välimaki M, Laitinen K, Ylikahri R. The effect of moderate alcohol intake on serum apolipoprotein A-I containing lipoproteins and lipoprotein(a). Metabolism 40: 1168–1172, 1991
Välimäki I, Hursti ML, Philakoski L, Vükari J. Exercise performance and serum lipids in relation to physical activity and serum lipids in relation to physical activity in schoolchildren. International Journal of Sports Medicine 3: 132–136, 1980
Verheugt FWA, Wouter ten Cate J, Sturk A, Imandt L, Verhorst PMJ, et al. Tissue plasminogen activator (t-PA) activity and inhibition in patients with myocardial infarction and normal coronary arteries. American Journal of Cardiology 59: 1075–1079, 1987
Vodak PA, Wood PD, Haskell WL, Williams PT. HDL-Cholesterol and other plasma lipid and lipoprotein concentrations in middleaged male and female tennis players. Metabolism 29: 745–752, 1980
Vyska K, Machulla H, Stremmel W, Faβbender D, Knapp W, et al. Regional myocardial free fatty acid extraction in normal and ischemic myocardium. Circulation 78: 1218–1233, 1988
Wallace MB, Moffatt RJ, Haymes EM, Green NR. Acute effects of resistance exercise on parameters of lipoprotein metabolism. Medicine and Science in Sports and Exercise 23: 199–204, 1991
Wilhelmsen L, Ssvärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. New England Journal of Medicine 311: 501–505, 1984
Williams KJ, Petrie KA, Brocia RW, Swenson TL. Lipoprotein lipase modulates net secretory output of apolipoprotein-B in vitro — a possible pathophysiologic explanation for familial combined hyperlipidemia. Journal of Clinical Investigation 88: 1300–1306, 1991
Williams PT, Krauss RM, Vranizan KM, Albers JJ, Terry RB, et al. Effects of exercise-induced weight loss on low density lipoprotein subfractions in healthy men. Arteriosclerosis 9: 623–632, 1989
Williams PT, Krauss RM, Vranizan KM, Wood PDS. Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation 81: 1293–1304, 1990
Williams PT, Krauss RM, Wood PD, Lindgren FT, Giotas C, et al. Lipoprotein subfractions of runners and sedentary men. Metabolism 35: 45–52, 1986
Williams PT, Wood PD, Haskell WL, Vranizan K. The effects of running mileage and duration on plasma lipoprotein levels. Journal of the American Medical Association 247: 2674–2679, 1982
Williams PT, Krauss RM, Vranizan KM, Albers JJ, Wood PDS. Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and thge particle size distribution of high density lipoproteins in men. Metabolism 41: 441–449, 1992
Williams RS, Logue EE, Lewis JL, Barton T, Stead NW, et al. Physical conditioning augments the fibrinolytic response to venous occlusion in healthy adults. New England Journal of Medicine 302: 987–991, 1980
Wirth A, Schlierf G, Schettler G. Körperliche Aktivität und Fettstoffwechsel. Klinische Wochenschrift 57: 1195–1201, 1979
Wood P, Haskell W. The effect of exercise on plasma high density lipoproteins. Lipids 14: 417–421, 1979
Wood PD, Haskell W, Klein H, Lewis S, Stern MP, et al. The distribution of plasma lipoproteins in middle-aged male runners. Metabolism 25: 1249–1257, 1976
Wood PD, Haskell WL, Blair SN, Williams PT, Krauss RM, et al. Increased exercise level and plasma lipoprotein concentrations: a one-year randomized, controlled study in sedentary middle-aged men. Metabolism 32: 31–39, 1983
Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. New England Journal of Medicine 319: 1173–1179, 1988
Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. New England Journal of Medicine 325: 461–466, 1991
Yalow RS, Glick SM, Roth J. Plasma insulin and growth hormone levels in obesity and diabetes. Annals of the New York Academy of Sciences 131: 357–373, 1965
Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell J. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arteriosclerosis and Thrombosis 13: 147–153, 1993
Zampogna A, Luria MH, Manubens SJ, Luria MA. Relationship between lipids and occlusive coronary disease. Archives of Internal Medicine 140: 1067–1069, 1980
Zöllner N, Tato F. Fatty acid compostion of the diet: impact on serum lipids and atherosclerosis. Clinical Investigation 70: 968–1009, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berg, A., Frey, I., Baumstark, M.W. et al. Physical Activity and Lipoprotein Lipid Disorders. Sports Med. 17, 6–21 (1994). https://doi.org/10.2165/00007256-199417010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00007256-199417010-00002